Gaurav Aggarwal's Net Worth
$126 Million
Who is Gaurav Aggarwal?
Gaurav Aggarwal has an estimated net worth of $126 Million. This is based on reported shares across multiple companies, which include HYPERION THERAPEUTICS INC, Sierra Oncology, Inc., Unicycive Therapeutics, Inc., Ocera Therapeutics, Inc., and GERON CORP.
SEC CIK
Gaurav Aggarwal's CIK is 0001551965
Past Insider Trading and Trends
2023 was Gaurav Aggarwal's most active year for acquiring shares with 8 total transactions. Gaurav Aggarwal's most active month to acquire stocks was the month of December. 2022 was Gaurav Aggarwal's most active year for disposing of shares, totalling 6 transactions. Gaurav Aggarwal's most active month to dispose stocks was the month of June. 2022 saw Gaurav Aggarwal paying a total of $27,939,656.40 for 1,280,277 shares, this is the most they've acquired in one year. In 2022 Gaurav Aggarwal cashed out on 5,660,995 shares for a total of $169,682,983.80, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HYPERION THERAPEUTICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5K |
$10.00 | $50,000.00 | 5K |
Jul 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sierra Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.74M |
$55.00 | -$150,471,915.00 |
0
|
Jul 1
| |||
Form 4
| +41.33% | 800K |
$27.00 | $21,600,000.00 | 2.74M |
Jan 31
| |||
Form 4
| +33.00% | 480.28K |
$13.20 | $6,339,656.40 | 1.94M |
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
∞
| 1.46M |
—
|
—
| 1.46M |
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Unicycive Therapeutics, Inc. (UNCY) Snapshot price: $1.1275
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 5
| |||
Form 4
|
∞
| 3.47M |
—
|
—
| 3.47M |
Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ocera Therapeutics, Inc. No price found
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +100.00% | 10K |
$2.15 | $21,500.00 | 20K |
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| +300.00% | 7.5K |
$3.62 | $27,150.00 | 10K |
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GERON CORP (GERN) Snapshot price: $1.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.97K |
—
|
—
| 1.97K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||